{"id":"W4381191604","doi":"10.7573/dic.2023-4-1","title":"Real-world experience of cabozantinib in Asian patients with advanced renal cell carcinoma following treatment with VEGFR tyrosine kinase inhibitors and/or immune checkpoint inhibitors","year":2023,"lang":"en","type":"article","venue":"Drugs in Context","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ipsen","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Clinical endpoint; Oncology; Nivolumab; Internal medicine; Pazopanib; Adverse effect; Population; Cancer; Clinical trial; Sunitinib; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001844749,0.0004661689,0.0008874878,0.0006448181,0.00006491043,0.00001799869,0.00009900058,0.00008633608,0.00001622073],"category_scores_gemma":[0.0000309685,0.0003094572,0.0001283656,0.001336546,0.0001774632,0.0001812435,0.00007859054,0.0002037333,0.000006575931],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005447249,"about_ca_system_score_gemma":0.0002353832,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00410857,"about_ca_topic_score_gemma":0.003093957,"domain_scores_codex":[0.9973313,0.00008198873,0.0008206314,0.0006768353,0.0005282226,0.0005609899],"domain_scores_gemma":[0.9987814,0.0001249207,0.0002799089,0.0005163439,0.00009208127,0.0002053007],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004851534,0.001056787,0.9276825,0.00017755,0.00005608838,0.001339996,0.02239862,0.00002256308,0.01607994,0.000009787173,0.0000108841,0.02631372],"study_design_scores_gemma":[0.02073006,0.004564496,0.6704716,0.001279138,0.0000835365,0.000006980007,0.009059512,0.00004356431,0.2932665,0.000002059965,0.0001604505,0.0003320824],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961164,0.0004804069,8.264732e-7,0.0001495552,0.0001371234,0.001502438,0.00001762453,0.00005482825,0.001540788],"genre_scores_gemma":[0.9981756,0.00007052156,0.0003466942,0.00002000702,0.0000374319,0.0003089901,0.0001116811,0.00007297772,0.000856063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2771866,"threshold_uncertainty_score":0.9999357,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01315660330541851,"score_gpt":0.2568507259529053,"score_spread":0.2436941226474868,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}